Viral Vectors: The Backbone of Cell and Gene Therapy
December 15, 2025
Cell and gene therapies (CGTs) have advanced from conceptual promise to clinical reality, with dozens of approved products and...
Read more →Last November we published POSTmark CAR-T: Delivering Therapies Without Delay, arguing that manufacturing continuity—not biology—is the rate-limiting step for most CAR-T programs....
Read More →December 15, 2025
Cell and gene therapies (CGTs) have advanced from conceptual promise to clinical reality, with dozens of approved products and...
Read more →